Skip to main content


West Syndrome Treatment Market Analysis As per DelveInsight, in 2020, the total West Syndrome diagnosed prevalent population was 8,601 in the seven major markets (i.e the USA, EU5, and Japan). The West Syndrome Market Size in 7MM was found to be USD 182.4 Million in 2020. Some of the key factors such as clinical development activities, product innovations, and technological advancements, support from various organizations, and the rising prevalence of infantile spasms are expected to drive the West Syndrome Market Growth in the coming years. Globally, some of the key companies in the West Syndrome Market involve INSYS Therapeutics, GW Pharmaceuticals, BioPharm Solutions, and several others.